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Abstract 
In this study we have investigated the transmembrane movement of short chain fluorescently labeled phospholipids across the inner 
membrane of Escherichiu coli. Exogenously added C,-NBD-labeled phospholipids rapidly flip across the inner membrane of E. coli, as 
was shown by a dithionite reduction assay applied to inverted inner membrane vesicles (IIMV) isolated from wild type E. coli cells. The 
rate of transmembrane movement of the phospholipid probes incorporated into IIMV is temperature dependent, and shows no 
phospholipid head group specificity. C,-NBD-labeled phospholipids translocate across the membrane of IIMV incubated at 37°C with a 
r,,, of 7 min. After the incorporation into IIMV C,-NBD-PG is partially converted to CL by CL-synthase. If IIMV are pretreated with 
proteinase K the conversion of this fluorescent probe to C,-NBD-CL is not observed anymore, suggesting that the catalytic domain of 
CL-synthase is at the cytoplasmic site of the plasma membrane of E. coli. Newly synthesized C,-NBD-CL also flips across the inner 
membrane although at a slower rate than the other phospholipid probes. The transmembrane movement occurs in both directions and is 
not influenced by treatment of the IIMV with a sulfhydryl reagent or a proteinase, nor by the presence of ATP, or a ApH across the 
membrane of the IIMV. However, the transmembrane movement of the C,-NBD-labeled phospholipid probes is not observed in LUVETs 
(large unilamellar vesicles made by extrusion technique) prepared of wild type E. coli lipids, indicating that the rapid transmembrane 
movement of phospholipids across the inner membrane of E. coli is a protein-mediated process. 
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1. Introduction 
Phospholipids are the major lipid component in Es- 
cherichia coli. The most abundant phospholipid in E. coli 
is phosphatidylethanolamine (PE), constituting about 75% 
of the total phospholipid content in the cell [I]. The two 
other phospholipids are phosphatidylglycerol (PG) and car- 
diolipin (CL), which account for about 20% and 5% of the 
total phospholipid content, respectively. The major part of 
Abbreviations: IIMV, inverted inner membrane vesicle(s); LUVET, 
large unilamellar vesicle made by extrusion technique; PE, phosphatidyl- 
ethanolamine; PG. phosphatidylglycerol; CL, cardiolipin; PS, phospha- 
tidylserine; TNBS, trinitrobenzenesulfonic acid; NBD, 7-nitrobenz-2-oxa- 
1,3-diazol; TLC, thin-layer chromatography; DTT, dithiothreitol; PMSF, 
phenylmethylsulfonyl fluoride; NEM, N-ethylmaleimide; Lep, leader pep- 
tidase; PhoA, alkaline phosphatase; BSA, bovine serum albumin, 
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the phospholipids is localized in the inner membrane in 
which they are the only lipid component [2,3]. 
The phospholipids in this membrane structure not only 
form the barrier between the cytosol and the periplasm, but 
also have a variety of other functions in the E. coli cell. 
Previous studies showed that specific phospholipid classes 
are involved in the regulation of enzyme activity, for 
instance PG affects the enzyme II of the phosphotrans- 
ferase system [4], and PE the enzyme glycerophosphate 
acyltransferase [5]. PG serves as precursor for the matura- 
tion of the major outer membrane lipoprotein [6] and the 
periplasmatically localized membrane-derived oligosaccha- 
rides [7]. Anionic phospholipids appear to be involved in 
DNA replication [8], and are involved in the process of 
protein translocation [9, lo]. Furthermore, the polymorphic 
properties of phospholipids appear to be required for cell 
viability [l 11. These processes are likely to require certain 
phospholipids at specific times on specific sites of the 
inner membrane. 
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With respect to the distribution of phospholipids in E. 
coli, it is known that PE is enriched in the outer membrane 
[3,12]. Surprisingly, knowledge on the topology of the 
phospholipids in the inner membrane is completely lack- 
ing. In the Gram-positive bacterium Bacillus megaterium 
it was shown by Rothman and Kennedy [ 131, using the 
amino reactive probe trinitrobenzene sulfonic acid that 
3 1% of the PE in the plasma membrane is situated in the 
outer leaflet. Furthermore, it was established that newly 
formed PE is partially transported over the plasma mem- 
brane of Bacillus megaterium at a rate 30000-times faster 
than the rate of spontaneous diffusion of PE across artifi- 
cial phospholipid membranes [ 141. 
The active sites of the enzymes involved in phospho- 
lipid synthesis localized so far, are at the cytosolic side of 
the inner membrane 1151. To reach their final destination, 
transport processes of phospholipids are required. Little, if 
anything, is known about sorting and transport of phospho- 
lipids in E. co/i. Langley et al. [ 161 showed in pulse chase 
studies, using a mutant E. coli strain lacking functional 
phosphatidylserine-decarboxylase at the non-permissive 
temperature, that the accumulating phosphatidylserine (PS) 
becomes evenly distributed between the inner and outer 
membrane. Interestingly, the PS present in the outer mem- 
brane could be chased back to the inner membrane. These 
results indicate that there is a bi-directional transport of 
phospholipids possible between the inner and outer mem- 
brane. 
To get insight in the transport of phospholipids in E. 
coli we started to investigate the transmembrane move- 
ment (flip-flop) of phospholipids across the inner mem- 
brane of E. coli, in an in vitro system using isolated 
inverted inner membrane vesicles (IIMV). The transmem- 
brane movement (flip-flop) of fluorescent 7-nitrobenz-2- 
oxa- 1,3-diazol-(NBD)-labeled short chain phospholipid 
analogues, incorporated into the IIMV, was studied, using 
the recently developed dithionite assay 1171. Dithionite is a 
membrane-impermeable reducing agent, which will only 
reduce the NBD-groups present in the outer leaflet of the 
membrane, leaving those that have moved to the inner 
leaflet intact. This assay has been successfully used to 
determine the time dependent transmembrane distribution 
of NBD-labeled phospholipids in the plasma membrane of 
erythrocytes [ 181, and to investigate the physiological role 
of the mouse mdr2 gene product expressed in yeast secre- 
tory vesicles [191. 
2. Materials and methods 
2.1. Chemicals 
1 -Palmitoyl-2-6-(7-nitrobenz-2-oxa- 1,3-diazol-4- 
yl)aminocaproyl-sn-glycero-3-phosphoethanolamine (C,- 
NBD-PE), C,-NBD-phosphatidylserine (C,-NBD-PS), C,- 
NBD-phosphatidylglycerol (C,-NBD-PG) and C,-NBD- 
phosphatidylcholine (C,-NBD-PC) were obtained from 
Avanti Polar Lipids (Birmingham, AL) and were pure as 
judged by TLC. Sodium dithionite was purchased from 
Sigma (St. Louis, MO). All other chemicals were analyti- 
cal grade. 
2.2. Growth of bacteria and preparation of imerted inner 
membrane vesicles (IIMV) 
In all experiments E. co/i wild type strain W3899 [20] 
was used. Cells were grown at 37°C in LB medium [21]. 
For the preparation of IIMV, overnight cultures were 
diluted 1:40 in LB medium and grown to an OD,,, of 
0.7-0.8 (late log phase). The cells were harvested and 
washed with cold physiological salt solution. Vesicles 
were isolated essentially as described [22]. Briefly, cells 
from a 3 1 culture were resuspended in 40 ml of buffer K 
(50 mM triethanolamine-HAc pH 7.5, 250 mM sucrose, 1 
mM EDTA). DTT and PMSF were added to 1 mM and 
0.375 mM, respectively. The cells were broken by passing 
the suspension twice through a French press at 8000 psi. 
After each cycle an extra 1 mM of DTT was added. Cell 
debris was removed by centrifuging twice at low speed (5 
min at 6000 X g). The outer membrane fraction was re- 
moved by centrifugation in a type 60 Ti rotor (Beckman): 
after the speed had increased to 165 000 X g it was main- 
tained for 1 min and then the run was ended. Inner 
membrane vesicles were pelleted at 165 000 X g for 90 
min in a type 60 Ti rotor. The crude IIMV were resus- 
pended in buffer K and layered on top of a discontinuous 
sucrose gradient in buffer M (buffer K without sucrose) 
according to Osbom et al. [2]. The gradients were cen- 
trifuged for 14- 18 h at 112 000 X g in an SW 28 rotor 
(Beckman), after which one broad band, containing the 
purified IIMV, was collected, diluted in buffer M, and 
centrifuged at 165 000 X g for 90 min. Vesicles were 
resuspended in buffer L (buffer K without EDTA), quickly 
frozen in liquid nitrogen and stored at - 80°C. The con- 
centration of IIMV was determined by their phosphorus 
content according to Rouser et al. [23]. 45% of the phos- 
phorus content is accounted for by phospholipids as was 
determined by a total lipid extraction according to Bligh 
and Dyer [24]. IIMV isolated as above are sealed and 
100% inside-out, as was recently shown by van Klompen- 
burg et al. [25]. 
2.3. Large unilamellar cesicles made by extrusion tech- 
nique (LUVETs) 
E. coli cells in the late log phase (see above) were 
harvested and lipids were extracted according to Bligh and 
Dyer. The crude lipid extract was dissolved in a small 
volume of chloroform and applied to a column packed 
with Silica 60 (Merck), which was first eluted with chloro- 
R.P.H. Huijhregts et al./ Biochimica et Biophysics Acta 1280 (1996~41-50 43 
form to remove traces of neutral lipids. Next the phospho- 
lipids were eluted with chloroform/methanol, 1: 1 (v/v) 
[26]. The purified total phospholipid extract was stored in 
CHCl, at -20°C. For the preparation of LUVETs, a dry 
lipid film was hydrated in buffer Z (50 mM tri- 
ethanolamine-HAc pH 7.5, 1 mM EDTA, 100 mM KCl). 
The resulting phospholipid suspension with a concentra- 
tion of 20 mM was extruded IO-times using 400 nm pore 
size polycarbonate filters [27]. The lipid concentration was 
determined according to Rouser et al. 1231. 
2.4. Dithionite assay 
C,-NBD-phospholipids were added from a stock solu- 
tion of about 1 mM in ethanol to an IIMV or LUVET 
suspension (0.5 mM phosphorus) in buffer Z on ice. The 
C,-NBD-phospholipid added was 0.4 mol% for the IIMV, 
and 0.2 mol% for the LUVETs with respect to the total of 
phospholipids. The final concentration of ethanol never 
exceeded 0.15% (v/v). After the addition of the fluores- 
cent probe the vesicle suspension was put on ice for 15 
min in order to facilitate incorporation of the probe. The 
dithionite assay was performed essentially as described by 
Meers et al. [28]. After different times of incubation at the 
temperatures indicated, aliquots of 100 nmol phosphorus 
of the vesicle suspension were put on ice. To these aliquots 
dithionite from a 1 M stock solution in 2 M Tris pH 11 
was added to a final concentration of 8 mM. After 20 min 
on ice, the vesicle suspension was centrifuged for 40 min 
at 315 000 X g at 2°C in a TLlOO ultracentrifuge (Beck- 
man). The pelleted vesicles were solubilized in 1.2 ml 
0.4% (v/v) Triton X-100 in buffer Z, and the C,-NBD- 
labeled phospholipids were quantified by fluorescence us- 
ing an SPF 500C fluorimeter (SLM Aminco) or an LSSOB 
fluorimeter (Perkin Elmer) at 25°C. The excitation wave- 
length was 470 nm, emission was measured at 540 nm 
(band widths: 5 nm). Possible hydrolysis of the NBD- 
labeled phospholipids after incorporation of the probes into 
IIMV was checked by TLC. No formation of fatty acid 
was observed during incubations of the IIMV up to 1 h at 
37°C. 
Upon incorporating C,-NBD-PG into IIMV, part of the 
fluorescent label was retrieved as C,-NBD-cardiolipin (C,- 
NBD-CL). In order to quantify the conversion of C,-NBD- 
PG to C,-NBD-CL, and to determine the dithionite-pro- 
tected pool of C,-NBD-CL, the phospholipids of the IIMV 
were analyzed by TLC, before and after treatment with 
dithionite. The IIMV pellet was resuspended in 100 ~1 0.1 
M HCl and the lipids were extracted according to Bligh 
and Dyer. The lipid extracts were applied to Silica 60 
plates (Merck) impregnated with 1.2% (w/v) boric acid 
[29] and the lipids were separated using 
chloroform/methanol/water/ammonia, 120:75:6:2 (v/v) 
as eluent. The positions of the fluorescent spots were 
determined under UV light, the silica was scraped off and 
collected in a Pasteur pipette on glass wool. The phospho- 
lipids were eluted from the silica using 6 ml 
CHCl,/MeOH, 1: 1 (v/v), and dried at 37°C under a 
stream of nitrogen. Subsequently the lipid film was solubi- 
lized in 0.4% (v/v) Triton X- 100 and the fluorescence was 
measured as described above. 
The effect of several factors on the transmembrane 
movement of C,-NBD-labeled phospholipids was investi- 
gated. IIMV were pretreated with 200 pug/ml proteinase 
K in buffer Z for 15 min at 37°C and put on ice for 10 min 
prior to the incorporation of the fluorescent probe. Alterna- 
tively, IIMV were pretreated with 2 mM N-ethylmalei- 
mide (NEM) in buffer Z for 30 min at 37°C and put on ice 
for 10 min before the addition of the fluorescent probe. 
The energy dependence of transmembrane movement was 
investigated by incubating the IIMV, with a C,-NBD- 
labeled phospholipid incorporated, at 37°C in the presence 
of 10 mM Mg*+-ATP in buffer Z. To investigate the effect 
of a pH gradient on the transmembrane movement, IIMV 
with the C,-NBD-labeled phospholipid incorporated, were 
incubated at 37°C with 5 mM lactate in buffer Z to induce 
a ApH [301. 
2.5. Assay for dithionite permeability in IIMV 
To check for dithionite leakage into the IIMV under the 
conditions used to measure the transmembrane distribution 
of the NBD-lipids, advantage was taken of the property of 
a Lep-PhoA fusion protein to form disulfide-bridged 
dimers. Leader peptidase (Lep) is an integral membrane 
protein with two transmembrane helices, connected by a 
small cytoplasmic loop, and a large catalytic domain in the 
periplasm [31]. Alkaline phosphatase (PhoA) is an enzyme 
normally present in the periplasm. Wild type E. coli strain 
W3899 was transformed with plasmid pLep-PhoA, which 
codes for a Lep-PhoA fusion protein under the arabinose 
promotor. Overnight cultures of W3899/pLep-PhoA were 
diluted 1:40 in LB media with 50 pg/ml ampicillin. After 
the culture had reached an OD,,, of 0.2, every 20 min an 
aliquot of arabinose was added to a final concentration of 
1% (w/v) and growth was continued until an OD,,, of 
0.7-0.8. was obtained. Cells were harvested and IIMV 
were isolated as described above, except that no DTT was 
used. 
IIMV of W3899/pLep-PhoA were treated as in the 
dithionite assay, except that instead of a C,-NBD-phospho 
lipid solution, only ethanol was added to a final concentra- 
tion of 0.15% (v/v). The dimer/monomer ratio of the 
Lep-PhoA fusion protein in the IIMV was analyzed by 
SDS-PAGE under non-reducing conditions (11% gel). The 
Lep-PhoA fusion protein was visualized by Western blot- 
ting and autoradiography with 35S-labeled protein A 
(Amersham, UK), and identified by its position on the gel, 
the dependency of its presence on induction, and its reac- 
tion with anti-Lep antibody. For quantification the bands 
of the monomer and dimer Lep-PhoA were scanned on a 
Phosphor Imager SI (Molecular Dynamics). 
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2.6. Incorporation of C,-NBD-labeled phospholipids in E. 
coli cells with a permeabilized outer membrane 
An overnight culture of W3899 was diluted 1:50 in LB 
media and grown to an OD,,, of 0.7. Cells from 2 ml of 
culture were harvested, washed with 1 ml of physiological 
salt solution (cold), and resuspended in 500 ~1 of an ice 
cold physiological salt solution containing 10 mM Tris-HCl 
pH 8.0, 5 mM EDTA, to permeabilize the outer membrane 
[32]. 500 pmol of C,-NBD-PS or C,-NBD-PG was added 
to the cell suspension on ice, followed by a 5 min incuba- 
tion. 200 ~1 samples were drawn and left on ice or put at 
37°C for 30 min. Subsequently the cells were collected by 
centrifugation and the phospholipids were extracted and 
analyzed by TLC as already described. Lipids isolated 
from cells in which C,-NBD-PG was incorporated were 
separated as described above. For the isolation of lipids 
from cells containing C,-NBD-PS, untreated Silica 60 
plates were used, and separation was achieved using 
CHCl,/MeOH/H,O, 65:25:4 (v/v) as eluent. Fluores- 
cence was measured as described above. 
3. Results 
3.1. Determination of C,-NBD-PE transmembrane distri- 
bution by dithionite 
To determine the transmembrane movement of different 
C,-NBD-labeled phospholipids, incorporated in the E. coli 
inner membrane from the cytoplasmic side, the dithionite 
assay was set up and applied to IIMV. 
First, the optimal conditions for the selective reduction 
of C,-NBD-labeled phospholipids present in the outer 
leaflet were established using LUVETs prepared from E. 
coli phospholipids. Fig. 1 shows that upon addition of 
dithionite from a 1 M stock, most of the C,-NBD-PE is 
reduced when it is incorporated in LUVETs by external 
addition. After an incubation for 20 min on ice, 8 mM 
dithionite has reduced most of the externally added label 
but only 40% of the label when this is symmetrically 
distributed in LUVETs, demonstrating that dithionite under 
these conditions does not penetrate the membrane. 
3.2. Transmembrane redistribution qf C,-NBD-PE in IIMV, 
but not in LlJVETs 
C,-NBD-PE was incorporated into IIMV and LUVETs, 
the vesicles were incubated for 1 h at 0°C or 37°C and 
subsequently treated with dithionite on ice. After the incu- 
bation the label is still present on PE as analyzed by TLC 
(data not shown). In the case of the IIMV, the protected 
pool of fluorescent label is about 4-fold higher at 37°C 
than at 0°C as shown in Fig. 2. This protected pool 
becomes accessible to dithionite when the vesicles are 
solubilized with Triton X-100. No significant change in 
I  
0 10 30 
time (min) 
Fig. 1. Time-course of the reduction on ice by dithionite of C,-NBD-PE 
present only in the outer leaflet (0) or in both leaflets (0) of LUVETs 
prepared from an E. co/i total phospholipid extract. A symmetrical 
distribution of C,-NBD-PE was obtained by incorporating the fluorescent 
probe in the lipid film prior to hydration. Dithionite was added to a final 
concentration of 8 mM at time zero. For experimental details see Section 
accessibility of C,-NBD-PE to dithionite is observed in 
LUVETs after incubation at 0°C or 37”C, with the pro- 
tected pool of C,-NBD-PE being similar to that found for 
IIMV incubated at 0°C. From the temperature dependent 
occurrence of protected C,-NBD-PE in IIMV, and from 
the fact that this protected pool can be reduced after 
solubilizing the vesicles with detergent, it is concluded that 
the probe has the ability to redistribute (flip) across the 
membrane. 5% of the NBD-label incorporated into IIMV 
can not be reduced even if the IIMV are solubilized with 
Triton X-100. This is due to the experimental conditions 
selected for the topology assay. Higher concentrations of 
dithionite are able to reduce all the label present both in 
- 25, 
IIMV LUVETs 
Fig. 2. Comparison of the C,-NBD-PE fluorescence, protected against 
reduction with dithionite in IIMV and LUVETs after incubating at 37°C 
(black bars) or 0°C (open bars). After incubating for I h at the tempera- 
ture indicated, vesicles were treated with dithionite, pelleted, and the 
fluorescence remaining was measured as described in Section 2. In a 
control experiment IIMV were incubated for I h at 37°C and solubilized 
with Triton X- 100 prior to the dithionite treatment (hatched bar). 
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Fig. 3. Treatment with dithionite does not reduce the disulfide bond of a Lep-PhoA fusion protein in IIMV. IIMV of W3899/pLep-PhoA were incubated 
for 1 h at 0°C (lanes 1 and 21, or 37°C (lanes 3 and 4), treated with dithionite (lanes 2 and 41 under identical conditions as used in the assay for 
transmembrane movement, and analyzed by SDS-PAGE under non-reducing conditions, followed by Western blotting using an anti-Lep antibody. An 
autoradiogram of the Western blot is shown with D denoting the dimer of Lep-PhoA, and M  the monomer. In lane 5 the IIMV were solubilized with 0.4% 
(v/v) Triton X-100 prior to treatment with dithionite. In the presence of dithionite for unknown reasons the monomer band shows a double appearance. 
intact and solubilized IIMV (on ice), but at these concen- 
trations dithionite permeates the membrane, as was de- 
tected in LUVETs symmetrically labeled with C,-NBD-PE 
(data not shown). Under the conditions used, dithionite 
does not permeate the membrane of LUVETs. However, 
this is not a guarantee that this is also the case for IIMV. If 
dithionite permeates the membrane of the IIMV the amount 
of protected C,-NBD-PE found may be an underestimate 
of the actual value. To check for this, a dithionite perme- 
ability assay was set up. 
3.3. Dithionite does not permeate the membrane of the 
IIMV 
IIMV isolated from cells of strain W3899/pLep-PhoA 
grown in the presence of arabinose, contain a Lep-PhoA 
fusion protein which can form disulfide-bridged homod- 
imers. This disulfide bridge is situated in the lumen of the 
IIMV. If dithionite penetrates the membrane it should be 
able to reduce the dimer. The loss of dimer is a measure of 
the extent of dithionite permeation. Fig. 3 shows that no 
loss of dimer is observed in the IIMV after treatment with 
Table 1 
Dithionite treatment of W3899/pLep-PhoA IIMV does not result in a 
loss of Lep-PhoA dimer * 
Temperature (“Cl Dithionite (8 mM) Dimer 
0 - 100+21 
0 + 103* 18 
31 - 100+24 
37 + 100+24 
Ob + 15+9 
’ IIMV of W3899/pLep-PhoA were treated as described in the legend of 
Fig. 3. Dimer and monomer bands were quantified with a Phosphor 
Imager, and the relative contribution of the dimer band to the total of the 
Lep-PhoA fusion protein was determined. The data are related to the 
intensity of the dimer band obtained after incubating for 1 h at 0°C 
without dithionite treatment. Values are presented f S.D. (n = 4). 
b Sample treated with Triton X-100. 
dithionite. The amounts of dimer present were quantified 
and the values are presented in Table 1. Lane 5 of Fig. 3 
shows that most of the dimer disappears if the vesicles are 
solubilized prior to the dithionite treatment, proving that 
dithionite reduces the disulfide bridge if it has access to it. 
It is concluded that no significant permeation of dithionite 
in IIMV occurs during the dithionite treatment, irrespective 
of the temperature of the incubation preceding the treat- 
ment with dithionite. 
3.4. Temperature dependence of transmembrane mocement 
of C,-NBD-PE 
The effect of temperature on the rate of transmembrane 
movement of C,-NBD-PE was investigated. After the in- 
corporation of C,-NBD-PE into IIMV, the vesicles were 
incubated at 0°C 25”C, or 37°C for several time intervals, 
time (min) 
Fig. 4. The rate of transmembrane movement of C,-NBD-PE in IIMV is 
temperature dependent. After incubation of the IIMV with C,-NBD-PE 
incorporated at 0°C (Cl), 25’C ( n l, and 37°C (0) for the indicated 
periods of time, IIMV were treated with dithionite, and the residual 
fluorescence was related to the original fluorescence intensity (i.e., the 
intensity before dithionite treatment). The error bars depict the standard 
deviation (n 2 3). 
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and subsequently treated with dithionite on ice. Fig. 4 
shows that the rate of transmembrane movement is temper- 
ature dependent. At 0°C the pool of fluorescence protected 
against reduction with dithionite is low (6%) and does not 
change during a 1 h period of incubation. However, at 
25°C and 37°C the pool of fluorescent label protected 
against reduction with dithionite increases in time and 
levels off at a maximum value which is higher after 
incubation at 37°C than at 25°C. At 37°C C,-NBD-PE 
moves across the inner membrane with an estimated t,,? 
of 7 min. 
3.5. Phospholipid specijkity of the transmembrane moue- 
ment 
To investigate whether transmembrane movement de- 
pends on the nature of the phospholipid head group, 
different C,-NBD-labeled phospholipids were incorporated 
into the IIMV after which the vesicles were incubated at 
37°C for several periods of time. Upon incorporation into 
IIMV, C,-NBD-PS is quickly (t,,, < 7 min) decarboxyl- 
ated to C,-NBD-PE by the enzyme PS-decarboxylase, 
even at low temperatures (data not shown). Using this 
biosynthetic route C,-NBD-PE is directed into the mem- 
brane in a similar way as is the case for PE in the in vivo 
situation. Fig. 5 shows that the phospholipid analogues 
tested, even the one resembling PC, which is not an 
endogenous lipid of E. coli, rapidly flip across the mem- 
brane of the IIMV. Furthermore, the rate of transmem- 
brane movement is similar for these phospholipid ana- 
logues, and a similar maximum level of fluorescence pro- 
tected against reduction is observed, which amounts to 
20% of the original fluorescence incorporated into the 
IIMV. The rates of transmembrane movement of C,-NBD- 
0 15 30 45 60 
time (min) 
Fig. 5. The rate of transmembrane movement at 37°C of C,-NBD-labeled 
phospholipids in IIMV is not dependent on the nature of the phospholipid 
head group. The experiments were performed as described in the legend 
of Fig. 4. The following fluorescent phospholipid analogues were added 
to IIMV: C,-NBD-PE (0). C,-NBD-PS CO), and C,-NBD-PC (0). 
Error bars are left away for clarity. Standard deviations never exceeded 
3% (n 2 3). 
front 
CL 
PG 
origin 
1 2 3 4 5 
Fig. 6. After the incorporation of C,-NBD-PG into IIMV it serves as a 
substrate for CL synthase when the IIMV are incubated at 37°C. After 
incubating the IIMV, with C,-NBD-PG incorporated, for I5 min at 0°C 
(lane l), or for 15 min (lane 2-4) or 60 min (lane 5) at 37”C, the 
phospholipids of IIMV were analyzed by TLC, and spots of NBD-labeled 
phospholipids were visualized by UV. IIMV were treated with proteinase 
K (200 pg/ml) for 15 min at 37°C and put on ice for 10 min prior to the 
incorporation of C,-NBD-PG (lane 3). Furthermore IIMV were treated 
with dithionite after the incubation at 37°C (lanes 4, 5). 
PE, directly incorporated into IIMV or generated out of 
incorporated C,-NBD-PS are similar, suggesting that the 
transmembrane movement of PE is not directly coupled to 
PS-decarboxylase activity. 
3.6. C,-NBD-PG: conversion into C,-NBD-CL and trans- 
membrane movement 
After the incorporation into IIMV, C,-NBD-PG was 
partially converted to NBD-labeled CL upon incubation at 
37°C (Fig. 6, lane 2). Incubating IIMV on ice did not result 
in the synthesis of C,-NBD-CL (Fig. 6, lane l), and upon 
proteinase K pretreatment (Fig. 6, lane 3) the conversion at 
37°C was completely blocked, suggesting that the active 
site of CL-synthase is at the cytoplasmic leaflet of the 
inner membrane. Fig. 7 shows that the conversion is rapid 
and levels off at 40% of the fluorescent label being 
converted into C,-NBD-CL. This conversion provides an 
opportunity to study the transmembrane transport of both 
the PG and CL analogues and in addition it allows to 
compare the kinetics of CL-synthesis with the kinetics of 
its subsequent transmembrane movement. In Fig. 6, lanes 4 
and 5 illustrate that part of both phospholipids flip across 
the membrane of IIMV, as they are not reduced by dithion- 
ite. This effect has been quantified and Fig. 8 shows that 
C,-NBD-PG moves across the membrane with a half-time 
of about 7 min, a value which is in the same order as the 
rates observed for the other phospholipid analogues in Fig. 
5. C,-NBD-CL moves across the membrane approx. 2.4- 
fold slower than C,-NBD-PG (Fig. 8). The rate of trans- 
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time (min) 
Fig. 7. Conversion of C,-NBD-PG (@I into C,-NBD-CL (0) by IIMV 
at 37°C. IIMV with C,-NBD-PG-incorporated were incubated at 37°C for 
several time periods. IIMV were pelleted, after which the phospholipids 
were extracted and applied to TLC. CL and PG spots were scraped off, 
the lipids eluted, and the associated fluorescence measured. The error 
bars depict the standard deviation (n = 3). 
membrane transport of C,-NBD-CL is approx. 1.7-fold 
slower than its rate of synthesis (compare Figs. 7 and 8). 
3.7. Which factors affect the transmembrane movement of 
C,-NBD-labeled phospholipids 
To investigate whether proteins are involved in the 
transmembrane movement of C,-NBD-labeled phospho- 
lipids, IIMV were either pretreated with proteinase K or 
NEM. Table 2 reveals that the process of transmembrane 
movement of C,-NBD-labeled PE, PS (decarboxylated to 
PE), and PG, is not influenced by the proteinase treatment 
and that the transmembrane movement of C,-NBD-PE is 
not affected by the pretreatment with NEM. Furthermore, 
it was checked whether the transmembrane movement of 
C,-NBD-labeled phospholipids is energy-dependent. The 
presence of a pH gradient (generated by 5 mM lactate) 
during the incubation at 37°C has no effect on the process 
time (min) 
Fig. 8. Time dependence of the protection from reduction by dithionite of 
C,-NBD-PC (01, and C,-NBD-CL (0) in IIMV. The data are expressed 
as a percentage of the total amount of the corresponding NBD-lipid 
present at each time point. After the incubation at 37°C vesicles were 
treated with dithionite and collected. IIMV were further treated as 
described in the legend of Fig. 7. The error bars depict the standard 
deviation (n = 3). 
of transmembrane movement (see Table 2). A decrease in 
the transmembrane movement of C,-NBD-labeled lipids is 
detected when IIMV are incubated for 15 min at 37°C in 
the presence of 10 mM Mg’+-ATP. However, this de- 
crease was also found when only Mg*+ was present 
during the incubation at 37°C. Therefore, the inhibitory 
effect on transmembrane movement observed for Mg’+- 
ATP most likely is caused by Mg’+. 
3.8. Transmembrane mouement of C,-NBD-labeled phos- 
pholipids in E. coli cells with a permeabilized outer mem- 
brane 
In the in vitro assay described above phospholipids 
analogues are inserted from the cytoplasmic side of the 
membrane. The ability of C,-NBD-labeled phospholipids 
to move from the outside to the inside of the inner 
Table 2 
The effect of a pretreatment of IIMV with proteinase K or NEM, or the presence of a ApH or Mg’+-ATP during the incubation at 37°C on the 
transmembrane movement of C,-NBD-labeled phospholipids in IIMV a 
C,-NBD-PE 
C,-NBD-PS b 
C,-NBD-PG ’ 
C,-NBD-PC 
Proteinase K NEM APH Energy source 
+ - + - + - - Mg*+-ATP Mg’+ 
17 17 23 21 I8 18 19 12 16 
18 17 ND ND 20 14 15 
16 16 ND 18 . 18 15 8 II 
ND ND ND 16 11 I1 
’ IIMV were pretreated as described in Section 2, and incubated for 15 min at 37°C after the addition of the C,-NBD-labeled phospholipid. The data are 
presented as the NBD-fluorescence remaining after dithionite reduction and expressed as percentage of the original fluorescence present. ND: not 
determined. 
b After C,-NBD-PS is added to IIMV it is rapidly decarboxylated to C,-NBD-PE. Proteinase K treatment had no effect on the decarboxylation. 
’ C,-NBD-PG is a substrate for CL-synthase, so the protected pool of fluorescent label depicted in the table in the absence of proteinase K contains both 
C,-NBD-PC and C,-NBD-CL. Proteinase K pretreatment blocks the conversion of PG to CL. The protected pool of fluorescent label now only contains 
C,-NBD-PG. 
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Table 3 
EDTA treated E. coli cells of wild type strain W3899 synthesize 
C,-NBD-PE and C,-NBD-CL from incorporated C,-NBD-PS and C,- 
NBD-PC, respectively ’ 
Incorporated Temperature C,-NBD-PE C,-NBD-CL 
NBD-lipid of incubation (5% of total (5% of total 
(“a b fluorescence) fluorescence) 
C,-NBD-PS 0 41+5 - 
C,-NBD-PS 37 82*4 - 
C,-NBD-PC 0 - 0 
C,-NBD-PG 37 - 50+2 
a The amounts of newly formed NBD-labeled phospholipids are shown as 
a percentage of the total fluorescence present on the TLC plate+S.D. 
(n = 3). 
b After incorporation of the NBD-labeled lipids, the cells were incubated 
for 30 min at the temperature indicated. 
membrane of E. coli cells was also investigated. For this 
purpose C,-NBD-labeled phospholipids were incorporated 
in cells of E. coli, of which the outer membrane was 
permeabilized by EDTA [32]. No major disintegration of 
the cells was observed, and the cells were homogeneously 
labeled with C,-NBD-phospholipid, as checked by fluores- 
cence microscopy (data not shown). Under these condi- 
tions 50-60% (data not shown) of the NBD-labeled phos- 
pholipid added becomes incorporated in the E. coli cells. 
The transmembrane movement was determined by the 
ability of the phospholipids to serve as substrates for the 
enzymes of the biosynthetic routes, which have their active 
sites at the cytoplasmic side of the inner membrane. The 
results in Table 3 indicate that both C,-NBD-PS and 
C,-NBD-PG after incorporation into EDTA-treated E. cofi 
cells, flip across the inner membrane. A large fraction of 
C,-NBD-PS is decarboxylated to C,-NBD-PE even when 
the cells are incubated at 0°C indicating that inward 
transmembrane movement of C,-NBD-PS already occurs 
at this temperature. The transmembrane movement of C,- 
NBD-PG at 0°C could not be determined because the 
enzyme CL-synthase is not active at this temperature (as 
shown in Fig. 6). However, at 37°C 50% of the C,-NBD- 
PG incorporated in the cells is converted to C,-NBD-CL 
(Table 31, demonstrating rapid inward transport of the PG 
analogue. 
4. Discussion 
In the present study we have investigated the transmem- 
brane movement of C,-NBD-labeled phospholipids across 
the inner membrane of E. coli in in vitro systems. Using a 
dithionite reduction assay, it was shown that C,-NBD- 
labeled lipids are able to rapidly flip across the membrane 
of E. coli inverted inner membrane vesicles (IIMV) in a 
temperature dependent way. At 37°C C,-NBD-PE equili- 
brates over the membrane of IIMV with a ti,* of 7 min. In 
contrast, in LUVETs prepared from wild type E. colt 
lipids, no transmembrane movement of C,-NBD-PE was 
detected, consistent with the reported slow flip-flop rates 
of natural phospholipids (t,,, of 80 days [33]) in artificial 
phospholipid bilayers. 
In the dithionite assay IIMV are incubated with 8 mM 
dithionite for 20 min on ice to reduce the fluorescent label 
present in the outer leaflet of the vesicles. Under these 
conditions dithionite is able to reduce 95% of the fluores- 
cent label when this is incorporated into IIMV on ice and 
therefore present in the outer leaflet of the IIMV only. The 
assay was set up in this way because other protocols did 
not work. The dithionite assay as described by McIntyre 
and Sleight [ 171, and Ruetz and Gros [ 191, where dithionite 
is added to vesicle suspensions at room temperature, did 
not work in the case of IIMV. On-line fluorescence mea- 
surements showed that no stable level of fluorescence is 
reached during the incubation with dithionite at room 
temperature (data not shown). Furthermore, flip-flop is 
likely to continue during the incubation at these higher 
temperatures, complicating the interpretation of the values 
obtained. The conditions of the dithionite assay were vali- 
dated in experiments with LUVETs, and with the use of a 
Lep-PhoA marker in the IIMV. In LUVETs not more than 
40% of the C,-NBD-PE is reduced when this is symmetri- 
cally distributed over the membrane, demonstrating that 
the label is selectively reduced in the outer leaflet. Dithion- 
ite does not permeate the membrane of IIMV as evidenced 
by the absence of any disulfide bridge reduction in the 
Lep-PhoA dimer. 
BSA extraction, which is a widely used method in 
determining the distribution of fluorescently labeled short 
chain phospholipid analogues, and spin-labeled phospho- 
lipid analogues over the plasma membrane of eukaryotes 
(for a review see [34]), did not work in the case of IIMV. 
After the incorporation of C,-NBD-PE into IIMV on ice, 
not more than about 70% of the probe could be re-ex- 
tracted after incubating for 30 min with 5% (w/v> BSA on 
ice. This number could not be increased by longer incuba- 
tion times or higher concentrations of BSA (data not 
shown). 
When the data are corrected for the fraction non-reduci- 
ble label it can be calculated that at equilibrium 15% of all 
C,-NBD-labeled phospholipids have moved across the in- 
verted inner membrane. The fact that for all C,-NBD- 
labeled lipids the rate of transmembrane movement is the 
same at 37°C indicates that this process in E. coli is not 
head group specific. Even C,-NBD-PC, an analogue of 
PC, a lipid class which is normally not present in E. coli 
cells, shows the same rate of transmembrane movement as 
the other lipid probes. This is in agreement with an earlier 
study of Langley et al. [16], which showed that in a psd 
mutant PS was transported from its site of synthesis to the 
outer membrane, thereby flipping across the inner mem- 
brane. PS is normally rapidly decarboxylated to PE and is 
therefore not present in the membranes of an E. coli cell. 
The fact that PS was flipped across the inner membrane 
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indicates that the machinery involved in this process is not 
specific for the endogenous E. coli phospholipids. 
The equilibrium distribution of - 6:1, 
cytoplasmic/periplasmic side obtained for the C,-NBD- 
labeled phospholipids is very unlikely to correspond to the 
distribution of the endogenous phospholipids across the E. 
coli inner membrane. Possibly, the transmembrane move- 
ment of C,-NBD-labeled lipids in the IIMV is restricted in 
the in vitro system. When C,-NBD-labeled phospholipids 
are added to the IIMV at a ten-fold lower concentration, 
the same distribution pattern is observed after a 1 h 
incubation at 37°C (data not shown), suggesting that it is 
not the amount of fluorescent probe incorporated into the 
IIMV that determines its transmembrane distribution ob- 
tained at equilibrium. It can not be excluded that the 
kinetics of transmembrane movement are different in the 
case of a lower amount of NBD-phospholipid. In the in 
vivo situation phospholipids are transported to the outer 
membrane or can be used in the periplasm for protein 
modification [6], and for the formation of periplasmatically 
localized membrane-derived oligosaccharides [7]. This 
could provide a sink for the phospholipid transport process 
which is most likely not present in the in vitro system. 
Therefore, transmembrane transport towards the periplas- 
mic side of the inverted inner membrane vesicle might 
stop at an early stage. 
The fact that C,-NBD-PS and C,-NBD-PG are used by 
the enzymes of the biosynthetic routes is an argument for 
the use of these artificial phospholipids as model for the 
endogenous phospholipids. C,-NBD-PS is, even at low 
temperatures, quickly converted into C,-NBD-PE by the 
PS-decarboxylase. By using this biosynthetic pathway C,- 
NBD-PE was introduced into the inner membrane via a 
route mimicking the in vivo situation. The rate of trans- 
membrane movement of the resulting C,-NBD-PE was 
similar to that obtained when this lipid analogue was 
directly incorporated into IIMV, indicating that transmem- 
brane movement of PE and decarboxylation of PS are 
processes that are not directly coupled. C,-NBD-PG was 
shown to be a substrate for the synthesis of C,-NBD-CL 
by CL-synthase. If IIMV were pretreated with proteinase 
K no C,-NBD-CL was synthesized from C,-NBD-PG, 
indicating that the catalytic domain of CL-synthase is 
situated at the cytosolic side of the membrane, as was 
found for the other phospholipid biosynthetic enzymes 
[151. 
The conversion of C,-NBD-PG to C,-NBD-CL only 
occurs at higher temperatures and is less rapid than the 
decarboxylation of C,-NBD-PS. This makes it a nice tool 
to investigate the transmembrane movement of a phospho- 
lipid generated in situ. C,-NBD-CL is rapidly synthesized 
at 37°C. After synthesis it is partially flipped across the 
membrane of IIMV, at a rate lower than the rate of 
synthesis, indicating that also the synthesis and transmem- 
brane movement of C,-NBD-CL are not directly coupled. 
The slower rate of the transmembrane movement of CL 
could have several causes. Possibly the slower rate of 
transmembrane movement of CL is simply due to its 
molecular structure with two negative charges in the head 
group and four acyl chains. Alternatively, the acyl chain 
composition may affect the flipping rate of the NBD- 
labeled phospholipids. It is assumed that each fluorescent 
labeled CL contains one NBD group. This assumption is 
based on the consideration that the amount of C,-NBD-PG 
is much less than the amount of endogenous PG. As a 
result C,-NBD-CL contains more long-chain fatty acids 
than the other fluorescent probes. The length of the fatty 
acids might cause the C,-NBD-CL to be more tightly 
packed in the membrane and consequently it will not flip 
as easily as the other probes. This reasoning suggests that 
the rate of transmembrane movement of the endogenous 
E. coli phospholipids is slower than that of the short chain 
NBD-labeled phospholipids reported here. In this context it 
should be added that Colleau et al. [35] have reported that 
the NBD label slows down the rate of phospholipid 
translocation in the plasma membrane of mammalian cells. 
As described in the literature (for review see [34]) 
several flip-flop processes of phospholipids in eukaryotic 
cells are sensitive to sulfhydryl reagents and/or dependent 
on a source of energy, indicative for a protein-mediated 
process. The rate and extent of the transmembrane move- 
ment in E. coli IIMV could not be altered by a pretreat- 
ment with proteinase K, NEM, or the presence of Mg’+- 
ATP or a ApH during the temperature incubation. The 
effect observed with Mg” -ATP was accounted for by 
Mg2+ (see Section 3). Possibly, Mg’+ might cause a 
tighter packing of the phospholipids, by diminishing elec- 
trostatic head group repulsion. This would make it more 
difficult for the fluorescent probe to flip across the mem- 
brane. Although no specificity was seen between the dif- 
ferent C,-NBD-labeled phospholipids, transmembrane 
movement did not occur in LUVETs at 37°C indicating 
that proteins are involved in this process. 
The ability of the fluorescent probe to serve as a 
substrate for the enzymes of the biosynthetic routes present 
at the cytoplasmic site of the inner membrane was used to 
demonstrate the transmembrane movement of C,-NBD- 
labeled phospholipids from the periplasmic to the cytoplas- 
mic leaflet of the inner membrane of E. coli. C,-NBD-PS 
and C,-NBD-PG are converted into C,-NBD-PE and C,- 
NBD-CL, respectively, upon incorporation into E. coli 
cells. This shows that indeed C,-NBD-PS and C,-NBD-PG 
are able to flip across the inner membrane of E. coli from 
the periplasmic side of the membrane, indicating that 
C,-NBD-labeled phospholipids can rapidly move across 
the inner membrane in both directions. 
Rapid transmembrane movement of both PC and PC 
analogues has previously been observed in rat liver micro- 
somes [36-381. Interestingly this process was also found to 
be energy-independent and lacked head group specificity 
[38]. The inner membrane of E. coli and the endoplasmic 
reticulum share one important characteristic, i.e., they are 
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the main site of de novo synthesis of phospholipids in the 
cell, and therefore must possess mechanisms for rapid 
transmembrane movement. The generation time of wild 
type E. coli is about 30 min. In this time the membrane 
structures and therefore the total amount of phospholipids 
are doubled. This implies that the half time of transmem- 
brane movement of phospholipids across the inner mem- 
brane is 15 min or less, which is close to the observed 
values. 
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